159 related articles for article (PubMed ID: 33661414)
1.
Mix M; Schultze-Seemann W; von Büren M; Sigle A; Omrane MA; Grabbert MT; Werner M; Gratzke C; Meyer PT; Jilg CA
EJNMMI Res; 2021 Mar; 11(1):22. PubMed ID: 33661414
[TBL] [Abstract][Full Text] [Related]
2. Performance of
Mix M; Reichel K; Stoykow C; Bartholomä M; Drendel V; Gourni E; Wetterauer U; Schultze-Seemann W; Meyer PT; Jilg CA
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2062-2070. PubMed ID: 30062606
[TBL] [Abstract][Full Text] [Related]
3. Results from extended lymphadenectomies with [
Jilg CA; Reichel K; Stoykow C; Rischke HC; Bartholomä M; Drendel V; von Büren M; Schultze-Seemann W; Meyer PT; Mix M
EJNMMI Res; 2020 Mar; 10(1):17. PubMed ID: 32144598
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
[No Abstract] [Full Text] [Related]
5. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Value of
Rauscher I; Düwel C; Wirtz M; Schottelius M; Wester HJ; Schwamborn K; Haller B; Schwaiger M; Gschwend JE; Eiber M; Maurer T
BJU Int; 2017 Jul; 120(1):40-47. PubMed ID: 27862863
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
[TBL] [Abstract][Full Text] [Related]
9. Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer.
Hinsenveld FJ; Wit EMK; van Leeuwen PJ; Brouwer OR; Donswijk ML; Tillier CN; Vegt E; van Muilekom E; van Oosterom MN; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2020 Apr; 61(4):540-545. PubMed ID: 31562222
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and preclinical evaluation of novel
Kunert JP; Müller M; Günther T; Stopper L; Urtz-Urban N; Beck R; Wester HJ
EJNMMI Res; 2023 Jan; 13(1):2. PubMed ID: 36645586
[TBL] [Abstract][Full Text] [Related]
11. The Value of
Su HC; Zhu Y; Hu SL; Liu C; Lin GW; Dai B; Zhang YJ; Ye DW
Ann Surg Oncol; 2019 Feb; 26(2):653-659. PubMed ID: 30324468
[TBL] [Abstract][Full Text] [Related]
12. [
Werner P; Neumann C; Eiber M; Wester HJ; Schottelius M
EJNMMI Res; 2020 May; 10(1):45. PubMed ID: 32382945
[TBL] [Abstract][Full Text] [Related]
13. Head to head comparison performance of
García-Pérez FO; Davanzo J; López-Buenrostro S; Santos-Cuevas C; Ferro-Flores G; Jímenez-Ríos MA; Scavuzzo A; Santana-Ríos Z; Medina-Ornelas S
Am J Nucl Med Mol Imaging; 2018; 8(5):332-340. PubMed ID: 30510850
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
15. Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.
Knipper S; Tilki D; Mansholt J; Berliner C; Bernreuther C; Steuber T; Maurer T; Graefen M
Eur Urol Focus; 2019 Jan; 5(1):50-53. PubMed ID: 30292421
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 Study of
Goffin KE; Joniau S; Tenke P; Slawin K; Klein EA; Stambler N; Strack T; Babich J; Armor T; Wong V
J Nucl Med; 2017 Sep; 58(9):1408-1413. PubMed ID: 28302763
[No Abstract] [Full Text] [Related]
17. Diagnostic Accuracy of
Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R
Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of
Wang T; Zhao L; Qiao W; Sun N; Zhao J; Xing Y
Front Oncol; 2023; 13():1165694. PubMed ID: 37333816
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
Vallabhajosula S; Nikolopoulou A; Babich JW; Osborne JR; Tagawa ST; Lipai I; Solnes L; Maresca KP; Armor T; Joyal JL; Crummet R; Stubbs JB; Goldsmith SJ
J Nucl Med; 2014 Nov; 55(11):1791-8. PubMed ID: 25342385
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of [
Farkas I; Sipka G; Bakos A; Maráz A; Bajory Z; Mikó Z; Czékus T; Urbán S; Varga L; Pávics L; Besenyi Z
Ther Adv Med Oncol; 2024; 16():17588359231221342. PubMed ID: 38249326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
